Abstract:Transforming growth factor-β (TGF-β) inhibits the proliferation of epithelial cells by altering the expression or function of various components of the cell cycle machinery. Expression of one of these components, cyclin A, is inhibited by TGF-β treatment. We have identified a 760-base pair fragment of the human cyclin A gene promoter that is sufficient to confer TGF-β responsiveness. Using this promoter fragment, we have developed a cyclin A-based luciferase reporter assay that quantitates the growth inhibitory effect of TGF-β in transient transfection assays. This assay was used to determine which domains of the type I (RI) and type II (RII) receptors were required for the antiproliferative effect of TGF-β. In parallel, the functionality of chimeric receptors, between RI and RII (RI-RII or RII-RI), was tested for TGF-β effect on gene expression using a reporter assay based on the plasminogen activator inhibitor type 1 (PAI-1) promoter. We found that TGF-β-induced inhibition of cyclin A expression was absent in RI or RII-deficient Mv1Lu cells and that this response was restored by expression of wild-type type I or type II receptors in these cells. Furthermore, expression of a single chimeric receptor, either RI-RII or RII-RI, did not confer cyclin A regulation by TGF-β. However, expression of two reciprocal chimeras (RI-RII and RII-RI) resulted in growth inhibition, similarly to wild-type receptors. In addition, chimeric receptors as well as mutant receptors with a deleted cytoplasmic domain and kinase-negative receptors inhibited TGF-β responsiveness in the cyclin A reporter assay in a dominant negative fashion. Finally, in both receptor types, the juxtamembrane domain preceding the kinase domain was essential for receptor function but the cytoplasmic tail was dispensable. Our results suggest that a functional TGF-β receptor complex is required for TGF-β-dependent down-regulation of cyclin A gene expression and illustrate the identical receptor requirements for TGF-β-induced growth inhibition and gene expression. Transforming growth factor-β (TGF-β) inhibits the proliferation of epithelial cells by altering the expression or function of various components of the cell cycle machinery. Expression of one of these components, cyclin A, is inhibited by TGF-β treatment. We have identified a 760-base pair fragment of the human cyclin A gene promoter that is sufficient to confer TGF-β responsiveness. Using this promoter fragment, we have developed a cyclin A-based luciferase reporter assay that quantitates the growth inhibitory effect of TGF-β in transient transfection assays. This assay was used to determine which domains of the type I (RI) and type II (RII) receptors were required for the antiproliferative effect of TGF-β. In parallel, the functionality of chimeric receptors, between RI and RII (RI-RII or RII-RI), was tested for TGF-β effect on gene expression using a reporter assay based on the plasminogen activator inhibitor type 1 (PAI-1) promoter. We found that TGF-β-induced inhibition of cyclin A expression was absent in RI or RII-deficient Mv1Lu cells and that this response was restored by expression of wild-type type I or type II receptors in these cells. Furthermore, expression of a single chimeric receptor, either RI-RII or RII-RI, did not confer cyclin A regulation by TGF-β. However, expression of two reciprocal chimeras (RI-RII and RII-RI) resulted in growth inhibition, similarly to wild-type receptors. In addition, chimeric receptors as well as mutant receptors with a deleted cytoplasmic domain and kinase-negative receptors inhibited TGF-β responsiveness in the cyclin A reporter assay in a dominant negative fashion. Finally, in both receptor types, the juxtamembrane domain preceding the kinase domain was essential for receptor function but the cytoplasmic tail was dispensable. Our results suggest that a functional TGF-β receptor complex is required for TGF-β-dependent down-regulation of cyclin A gene expression and illustrate the identical receptor requirements for TGF-β-induced growth inhibition and gene expression.

Repression of cyclin D1 expression does not contribute to initiation or maintenance of cell transformation by adenovirus type 5 E1

Promotive Effect of Decreased Cyclin E Threshold on Cell Proliferation

Repression of P53-Mediated Transcription by Adenovirus E1B 55-Kda Does Not Require Corepressor Msin3a and Histone Deacetylases*

E2F1 Promotes Cell Cycle Progression by Stabilizing Spindle Fiber in Colorectal Cancer Cells

Cyclin A but not cyclin D1 is essential for c-myc-modulated cell-cycle progression.

Epigenetic Reprogramming by Adenovirus E1a

The Human Adenovirus E4-ORF1 Protein Subverts Discs Large 1 to Mediate Membrane Recruitment and Dysregulation of Phosphatidylinositol 3-Kinase

Cyclin E Overexpression in the Drosophila Accessory Gland Induces Tissue Dysplasia.

Cyclin D1 Affects Epithelial–mesenchymal Transition in Epithelial Ovarian Cancer Stem Cell-Like Cells

Notch1-induced Transformation of RKE-1 Cells Requires Up-Regulation of Cyclin D1.

Overexpression of Caveolin-1 Inhibits Endothelial Cell Proliferation by Arresting the Cell Cycle at G0/G1 Phase

[The Influence on Expression of Cyclin D1 by Anti-Sense Oligonucleotide Expression Vector].

Adenovirus 5 E1A-mediated Tumor Suppression Associated with E1A-mediated Apoptosis in Vivo

Dissecting the Roles of E1A and E1B in Adenoviral Replication and RCAd-enhanced RDAd Transduction Efficacy on Tumor Cells.

Transforming Growth Factor-β (TGF-β)-induced Down-regulation of Cyclin A Expression Requires a Functional TGF-β Receptor Complex

Interaction Between Cyclin-Dependent Kinases and Human Papillomavirus Replication-Initiation Protein E1 is Required for Efficient Viral Replication

Cyclin D- and E-Dependent Kinases and the P57(Kip2) Inhibitor: Cooperative Interactions in Vivo

Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F

Adenovirus-mediated Expression of Both Antisense Ornithine Decarboxylase and S-adenosylmethionine Decarboxylase Induces G1 Arrest in HT-29 Cells

Reexpression of Neu-Encoded Oncoprotein Counteracts the Tumor-Suppressing but Not the Metastasis-Suppressing Function of E1a

INHIBITION EFFECT OF Cyclind1 ON CELL PROLIFERATION AND TRANSCRIPTION OF Cycline, CDK2 AND P21cip1 IN HUMAN BREAST CANCER CELL LINE